Novavax, Inc. (NVAX)

Novavax Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,079	682.16	983.71	1,982	1,146	475.6
Revenue Growth (YoY)	9.22%	-30.65%	-50.37%	72.89%	141.02%	2448.48%
Cost of Revenue	461.86	569.64	1,037	2,071	2,535	747.03
Gross Profit	616.86	112.52	-53.55	-89.48	-1,388	-271.43
Selling, General & Admin	229.61	323.59	457.45	488.69	298.36	142.59
Research & Development	20.87	20.87	41.21	66.57	-	-
Operating Expenses	250.48	344.45	498.66	555.26	298.36	142.59
Operating Income	366.39	-231.93	-552.21	-644.74	-1,687	-414.02
Interest Expense	-23.56	-20.08	-14.42	-19.88	-21.13	-15.15
Currency Exchange Gain (Loss)	-5.8	-4.4	7.9	-2.5	-5.3	9.6
Other Non Operating Income (Expenses)	57.31	44.84	30	13.47	-1.53	4.01
EBT Excluding Unusual Items	394.34	-211.56	-528.73	-653.65	-1,715	-415.56
Merger & Restructuring Charges	-14.9	-17	-14.3	-	-	-2.7
Gain (Loss) on Sale of Assets	51.95	51.95	-	-	-	-
Pretax Income	431.39	-176.62	-543.03	-653.65	-1,715	-418.26
Income Tax Expense	8.56	10.88	2.03	4.29	29.22	-
Net Income	422.82	-187.5	-545.06	-657.94	-1,744	-418.26
Net Income to Common	422.82	-187.5	-545.06	-657.94	-1,744	-418.26
Shares Outstanding (Basic)	161	152	101	78	74	58
Shares Outstanding (Diluted)	168	152	101	78	74	58
Shares Change (YoY)	30.54%	51.03%	28.89%	5.08%	29.27%	138.81%
EPS (Basic)	2.63	-1.23	-5.41	-8.42	-23.44	-7.27
EPS (Diluted)	2.54	-1.23	-5.41	-8.42	-23.44	-7.27
Free Cash Flow	-635.71	-100.32	-767.74	-504.99	268.45	-97.01
Free Cash Flow Per Share	-3.78	-0.66	-7.62	-6.46	3.61	-1.69
Gross Margin	57.18%	16.50%	-5.44%	-4.52%	-121.10%	-57.07%
Operating Margin	33.97%	-34.00%	-56.14%	-32.53%	-147.13%	-87.05%
Profit Margin	39.20%	-27.49%	-55.41%	-33.20%	-152.12%	-87.94%
Free Cash Flow Margin	-58.93%	-14.71%	-78.05%	-25.48%	23.42%	-20.40%
EBITDA	407.51	-183.44	-510.99	-615.68	-1,674	-409.13
EBITDA Margin	37.78%	-26.89%	-51.94%	-31.07%	-146.03%	-86.02%
D&A For EBITDA	41.12	48.5	41.23	29.05	12.66	4.89
EBIT	366.39	-231.93	-552.21	-644.74	-1,687	-414.02
EBIT Margin	33.97%	-34.00%	-56.14%	-32.53%	-147.13%	-87.05%
Revenue as Reported	1,079	682.16	983.71	1,982	1,146	475.6
Advertising Expenses	-	33.7	91.5	84	8.9	-

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q